Bioactive Compounds
-
B7108 FexaramineSummary: farnesoid X receptor agonist -
B7127 PD 135158Summary: CCK2 receptor antagonist -
B7160 Zoniporide dihydrochlorideSummary: Sodium-hydrogen exchanger isoform 1 (NHE1) inhibitor -
B7209 B2Summary: Promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease -
B7275 NBI 35965 hydrochlorideTarget: CRF1 ReceptorsSummary: CRF1 antagonist -
B7352 CD 3254Summary: RXRα agonist,potent and selective -
B7484 SR 48692Summary: nonpeptide neurotensin antagonist -
B7498 A 1120Summary: retinol-binding protein 4 (RBP4) ligand -
B7621 OctMABSummary: Dynamin inhibitor -
B7625 GW 803430Summary: melanin-concentrating hormone receptor 1 (MCH1) antagonist
